Millendo Therapeutics Inc

MLND NASDAQ
10.70
-0.03
-0.28%
盘后: 10.70 0 0.00% 16:51 07/23 EDT
开盘
10.97
昨收
10.73
最高
10.99
最低
10.62
成交量
2.63万
成交均量(3M)
5.61万
52周最高
17.34
52周最低
6.77
换手率
0.20%
市值
1.43亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Millendo Therapeutics Inc MLND股票价格,Millendo Therapeutics Inc股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Millendo Therapeutics, Inc., formerly OvaScience, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing novel treatments for orphan endocrine diseases. The Company is focused on advancing two product candidates to treat three indications. Its advanced product candidate, livoletide (AZP-531), is a potential treatment for Prader-Willi syndrome (PWS), which is a rare and complex genetic endocrine disease characterized by hyperphagia, or insatiable hunger. It is also developing nevanimibe (ATR-101) with a primary focus on treating patients with classic congenital adrenal hyperplasia (CAH), which is a rare, monogenic adrenal disease that requires lifelong treatment with exogenous cortisol.
展开 >

最近浏览

名称
价格
涨跌幅